These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20068555)

  • 21. Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide.
    Fletcher S; Honeyman K; Fall AM; Harding PL; Johnsen RD; Wilton SD
    J Gene Med; 2006 Feb; 8(2):207-16. PubMed ID: 16285002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
    Maruyama R; Yokota T
    Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.
    Yin H; Moulton HM; Seow Y; Boyd C; Boutilier J; Iverson P; Wood MJ
    Hum Mol Genet; 2008 Dec; 17(24):3909-18. PubMed ID: 18784278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice.
    Lu-Nguyen NB; Jarmin SA; Saleh AF; Popplewell L; Gait MJ; Dickson G
    Mol Ther; 2015 Aug; 23(8):1341-1348. PubMed ID: 25959011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.
    Jirka SMG; 't Hoen PAC; Diaz Parillas V; Tanganyika-de Winter CL; Verheul RC; Aguilera B; de Visser PC; Aartsma-Rus AM
    Mol Ther; 2018 Jan; 26(1):132-147. PubMed ID: 29103911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice.
    Gao X; Shen X; Dong X; Ran N; Han G; Cao L; Gu B; Yin H
    Mol Ther Nucleic Acids; 2015 Oct; 4(10):e255. PubMed ID: 26440599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.
    Chen S; Le BT; Chakravarthy M; Kosbar TR; Veedu RN
    Sci Rep; 2019 Apr; 9(1):6078. PubMed ID: 30988454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO.
    Yin H; Moulton HM; Betts C; Merritt T; Seow Y; Ashraf S; Wang Q; Boutilier J; Wood MJ
    Mol Ther; 2010 Oct; 18(10):1822-9. PubMed ID: 20700113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CPP-directed oligonucleotide exon skipping in animal models of Duchenne muscular dystrophy.
    Yin H; Moulton H; Betts C; Wood M
    Methods Mol Biol; 2011; 683():321-38. PubMed ID: 21053140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of Japanese patients to development of antisense therapy for DMD.
    Matsuo M; Takeshima Y; Nishio H
    Brain Dev; 2016 Jan; 38(1):4-9. PubMed ID: 26094594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
    Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
    Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.
    van Putten M; Tanganyika-de Winter C; Bosgra S; Aartsma-Rus A
    Nucleic Acid Ther; 2019 Apr; 29(2):92-103. PubMed ID: 30672725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.
    Wilton SD; Lloyd F; Carville K; Fletcher S; Honeyman K; Agrawal S; Kole R
    Neuromuscul Disord; 1999 Jul; 9(5):330-8. PubMed ID: 10407856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy.
    Mann CJ; Honeyman K; McClorey G; Fletcher S; Wilton SD
    J Gene Med; 2002; 4(6):644-54. PubMed ID: 12439856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomers.
    Popplewell LJ; Malerba A; Dickson G
    Methods Mol Biol; 2012; 867():143-67. PubMed ID: 22454060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle.
    Gebski BL; Mann CJ; Fletcher S; Wilton SD
    Hum Mol Genet; 2003 Aug; 12(15):1801-11. PubMed ID: 12874101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
    Nik-Ahd F; Bertoni C
    Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renadirsen, a Novel 2'OMeRNA/ENA
    Ito K; Takakusa H; Kakuta M; Kanda A; Takagi N; Nagase H; Watanabe N; Asano D; Goda R; Masuda T; Nakamura A; Onishi Y; Onoda T; Koizumi M; Takeshima Y; Matsuo M; Takaishi K
    Curr Issues Mol Biol; 2021 Sep; 43(3):1267-1281. PubMed ID: 34698059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splice modification to restore functional dystrophin synthesis in Duchenne muscular dystrophy.
    Wilton SD; Fletcher S
    Curr Pharm Des; 2010; 16(8):988-1001. PubMed ID: 20041827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.